Fig. 3
From: Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
Evaluation of the effect of MSC with different treatment on rat liver fibrosis. A Animal modeling and treating diagram. B HE staining and Sirius Red staining of liver tissues in Normal (n = 3), Control (n = 5), MSC (n = 5), and Pre-MSC groups (n = 5). Scale bars, 50 μm C The positive area of Sirius Red staining statistics in Normal, Control, MSC, and Pre-MSC groups. D Biochemical index (AST, ALT, ALB, TBil) checked in Normal, Control, MSC, and Pre-MSC groups. *P < 0.05, **P < 0.01, ***P < 0.001